The Global Innovation Policy Center (GIPC) of the U.S. Chamber of Commerce highlighted the importance of the USTR's Special 301 Report, which evaluates more than 100 trading partners annually. The GIPC noted that the 2024 report had significant omissions regarding challenges to U.S. IP frameworks, leading to concerns from American industries. However, the 2025 report, which added eight countries to the Priority Watch List, addressed these issues, particularly surrounding Mexico's delays in enforcing provisions of the USMCA regarding IP protections.
New language emphasizes the importance of providing U.S. innovators with full and fair opportunities to use their IP and calls out foreign markets that fail to appropriately recognize the value of innovative medicines and medical devices.
Collection
[
|
...
]